Navigation Links
Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
Date:2/12/2008

NEW YORK, Feb. 12 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced that the company's Board of Directors has elected James M. Cornelius chairman of the Board. Mr. Cornelius, who was named chief executive officer in September 2006, will continue serving in that role as well. Mr. Cornelius' current employment contract, which expires in May 2009, will be terminated. The Board also named Lewis B. Campbell, chairman, president and CEO, Textron Inc., as lead independent director. James D. Robinson III, co-founder and general partner, RRE Ventures, resigned as non- executive chairman of the Board, a position he has held since June 2005. He will remain a director of the company until May 6, 2008, the date of the company's Annual Meeting of Stockholders, when he will retire pursuant to the Board's mandatory age retirement policy.

"Speaking for the entire Board, we're delighted that Jim Cornelius will be our next chairman at a critical time when Bristol-Myers Squibb is undergoing a fundamental transformation to a next generation BioPharma company," said Mr. Robinson. "Under Jim's leadership, Bristol-Myers Squibb has been put back on the path of growth, greater profitability and a renewed focus on helping patients prevail over serious diseases. We're confident that as chairman, he and his outstanding leadership team will succeed in their goal of making this a dynamic BioPharma company for the future."

Mr. Cornelius was named CEO of Bristol-Myers Squibb on April 30, 2007, after serving as interim CEO since September 12, 2006. He joined the Board in January 2005.

"I am excited by this tremendous opportunity to serve as chairman of the Board of this great company," said Mr. Cornelius. "Over the past
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Bristol-Myers Squibb to Acquire Adnexus Therapeutics
3. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
4. Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
5. Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
6. EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services
7. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
8. Bristol-Myers Squibb to Announce Results for the Fourth Quarter and Full Year of 2007 on January 31
9. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. KGI Elects Three New Members to Board of Trustees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... -- About POCT POCT, also ... laboratory. It helps in making fast clinical decisions, ... POCT is gaining popularity due to the increasing ... diabetes, heart disease, and obesity. It is generally ... minimize errors during the diagnosis of patients. POCT ...
(Date:9/18/2014)... Bryan-College Station, Texas (PRWEB) September 18, 2014 ... University System Chancellor John Sharp, Texas A&M Health ... from the U.S. Department of Health and Human ... GSK today dedicated a national pandemic influenza vaccine ... will serve as an anchor for the Texas ...
(Date:9/18/2014)... 18, 2014 Research and Markets ... Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - ... offering. The global companion diagnostics market ... from 2014 to 2019. Factors such as rising need ... companion diagnostics by the pharmaceutical industry, support from regulatory ...
(Date:9/18/2014)... 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY ... but separate underwritten offerings of 10,000,000 shares of its ... $2.00 per share, for expected gross proceeds of $20 ... Preferred Stock at a price to the public of ... million. Each share of Series A Convertible Preferred Stock ...
Breaking Biology Technology:POCT Market in China 2014-2018 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 2Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 3Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3
... (Alternext: ALCLS), the French genome engineering specialist, and the ... Kyoto University, Kyoto, Japan, have announced today that they ... engineering technologies with CiRA,s induced pluripotent stem cell (iPS) ... for use as cellular tools. CiRA ...
... PALO ALTO, Calif., Oct. 24 Wilson Sonsini ... services to technology, life sciences, and growth enterprises ... opened an office in Hong Kong. ... "China is an incredibly vibrant market—one that we ...
... 22 Trius Therapeutics, Inc. (Nasdaq: TSRX ) ... Trius Therapeutics, will present "Innovative Antibacterial Drugs by Design; The ... taking place on October 26, 2010 from 5:30-9:30 p.m. PT. ... at http://sdbn.org/october . About Trius ...
Cached Biology Technology:Cellectis and the Center for iPS Cells Research and Application Enter Collaboration 2Cellectis and the Center for iPS Cells Research and Application Enter Collaboration 3Wilson Sonsini Goodrich & Rosati Opens Hong Kong Office 2
(Date:9/18/2014)... have built the first smartphone app that automatically ... trends. In other words, your smartphone knows your ... -- and how that affects you. , The ... and loneliness to their academic performance, also may ... example, to monitor mental health, trigger intervention and ...
(Date:9/18/2014)... from several disciplines will be celebrated tonight at the ... in improving the health of premature infants and in ... The researchers, whose work was supported by the National ... former Atomic Energy Commission, will be honored at a ... A bipartisan group of Members of Congress will be ...
(Date:9/18/2014)... stressed they are often grouchy, grumpy, nasty, distracted or ... EPFL have just highlighted a fundamental synaptic mechanism that ... of social skills and cognitive impairment. When triggered by ... the brain. This was revealed by a work published ... team went to look for answers in a region ...
Breaking Biology News(10 mins):New Dartmouth smartphone app reveals users' mental health, performance, behavior 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 43rd annual Golden Goose award ceremony honors 8 researchers; Unusual work had big results 2How stress tears us apart 2
... It may take a legion of scuba divers armed with nets ... that controlling lionfish populations in the western Atlantic Ocean can pave ... it,s one speared fish at a time, it finally appears that ... University, Simon Fraser University and other institutions have shown in both ...
... is a wide-ranging and accessible book which serves as ... help us understand the boundaries between physics, on the ... other. From cooperation and criticality to flock ... topics belonging to the broad theme of complexity. He ...
... , This news release is available ... , High-protein diets, like the popular Dr. Dukan diet, increase ... negative effect on renal urinary and morphological markers. What,s more, ... because they drastically reduce urinary citrate (an inhibitor of calcium ...
Cached Biology News:War on lionfish shows first promise of success 2War on lionfish shows first promise of success 3High-protein diets, like the Dukan diet, increase the risk of developing kidney disease 2
Monoclonal Anti-Cystatin A tissue culture supernatant Solution containing 15 mM sodium azide human cystatin A ...
... Series are a line of pre-integrated ... fast and reliable automated solutions to ... "automation-friendly" building blocks, Caliper has created ... than conventional approaches, take up little ...
... Guava has made microcapillary flow cytometry accessible ... experts alike will appreciate the latest addition ... Pluseasy to use, surprising affordable, and very ... system includes such features as absolute cell ...
... Rotator, variable speed, timer, SB3, Fully ... Choice of tube holders to hold a ... The SB3 is ideal for aerating cultures, ... general mixing applications., The rotator can be ...
Biology Products: